ctDNA positivity post-NAT was associated with inferior DFS (<i>p</i> = 0.003).<h4>Conclusion</h4>ctDNA was a strong predictor of recurrence in rectal cancer, including in NOM settings. Here, BRD2 is linked to rectal cancer.